Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $14.59 million. The enterprise value is $5.22 million.

Market Cap	14.59M
Enterprise Value	5.22M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CMMB has 5.17 million shares outstanding. The number of shares has increased by 67.27% in one year.

Current Share Class	n/a
Shares Outstanding	5.17M
Shares Change (YoY)	+67.27%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	16.73%
Owned by Institutions (%)	20.48%
Float	4.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.50
P/TBV Ratio	1.50
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.42

Current Ratio	7.42
Quick Ratio	7.32
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -120.16% and return on invested capital (ROIC) is -79.03%.

Return on Equity (ROE)	-120.16%
Return on Assets (ROA)	-61.70%
Return on Invested Capital (ROIC)	-79.03%
Return on Capital Employed (ROCE)	-130.65%
Revenue Per Employee	n/a
Profits Per Employee	-$591,300
Employee Count	20
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.50% in the last 52 weeks. The beta is 0.55, so CMMB's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-60.50%
50-Day Moving Average	3.86
200-Day Moving Average	5.54
Relative Strength Index (RSI)	21.40
Average Volume (20 Days)	147,853

Short Selling Information

Short Interest	130,446
Short Previous Month	103,945
Short % of Shares Out	2.53%
Short % of Float	n/a
Short Ratio (days to cover)	1.39

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.67M
Pretax Income	-19.36M
Net Income	-11.83M
EBITDA	-12.61M
EBIT	-12.67M
Earnings Per Share (EPS)	-$2.12

Balance Sheet

The company has $9.37 million in cash and n/a in debt, giving a net cash position of $9.37 million or $1.81 per share.

Cash & Cash Equivalents	9.37M
Total Debt	n/a
Net Cash	9.37M
Net Cash Per Share	$1.81
Equity (Book Value)	9.70M
Book Value Per Share	1.87
Working Capital	9.18M

Cash Flow

Operating Cash Flow	-14.34M
Capital Expenditures	n/a
Free Cash Flow	-14.34M
FCF Per Share	-$2.77

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-67.27%
Shareholder Yield	-67.27%
Earnings Yield	-81.07%
FCF Yield	-98.29%

Analyst Forecast

The average price target for CMMB is $26.50, which is 839.72% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.50
Price Target Difference	839.72%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-42.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 26, 2025
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1